Insight Molecular Diagnostics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $32 | $1,139 | $260 | $518 |
Gross Profit | -605 | 496 | 139 | 350 |
EBITDA | -3,636 | -22,366 | -10,241 | -9,158 |
EBIT | -4,267 | -22,929 | -10,825 | -9,717 |
Net Income | -4,290 | -22,955 | -10,854 | -9,742 |
Net Change In Cash | 32 | 1,139 | 260 | 518 |
Free Cash Flow | -8,252 | -7,024 | -5,552 | -6,628 |
Cash | 28,201 | 11,583 | 18,692 | 24,287 |
Basic Shares | 34,519 | 30,476 | 32,033 | 32,023 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,055 | $1,881 | $1,503 | $958 |
Gross Profit | 190 | 740 | 413 | -18 |
EBITDA | -47,916 | -59,015 | -23,123 | -13,309 |
EBIT | -50,113 | -60,579 | -24,803 | -18,529 |
Net Income | -50,222 | -60,663 | -27,781 | -72,902 |
Net Change In Cash | 4,055 | 1,881 | 1,503 | 958 |
Free Cash Flow | -25,369 | -21,229 | -23,606 | -49,908 |
Cash | 11,583 | 8,636 | 9,432 | 19,993 |
Basic Shares | 30,476 | 13,071 | 7,651 | 5,540 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.12 |
2025-12-31 | -$0.72 |
2025-09-30 | -$0.23 |
2025-06-30 | -$0.30 |